Drug Discovery Product Showcase
-
Serum-Free, Xeno-Free Systems For Culture And Differentiation Of hMSCs
8/30/2022
Sartorius offers a novel serum-free (SF) and xeno-free (XF) culture system as well as MSC NutriStem® media, which enable long-term growth of hMSCs from various sources while retaining self-renewal and multi-lineage differentiation potential.
-
Cell Therapy Product Characterization Services
8/29/2022
Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.
-
Sartorius Cell Bank Manufacturing & Characterization Services
8/26/2022
Utilizing our CRO expertise, our highly experienced team have expanded our service offering to include cell bank manufacturing as well as comprehensive biosafety testing services.
-
Essential In Vivo Safety /Tox Studies To Move Your Molecule From Target To IND Successfully
7/28/2022
For a molecule to progress smoothly from early-stage discovery to the IND phase and further to successful clinical trials, the data from preclinical trials must be accurate and reliable.
-
Monoclonal Antibodies (mAbs) 2000 L 5 g/L Platform Accelerator℠ Integrated Solutions
7/20/2022
Learn how we can help you select a process model that's perfect for you and ensure that it's adapted to meet your precise needs.
-
Discovery Services: Putting Science To Work
6/29/2022
Our Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development.
-
Single-Use Supply Chain: The Distinct Advantage Of The Advanced Central Management System (ACMS)
6/6/2022
This fully validated solution to support a Quality by Design approach to single-use assembly design and production. It ensures the delivery of high-quality, fit-for-purpose, single-use systems with strong documentation packages.
-
ÄKTA oligosynt™ Oligonucleotide Synthesizer
3/28/2022
The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.
-
Accelerator℠ Integrated Platform Solution for Adherent Lentivirus (LV)
3/25/2022
Learn more about our end-to-end process support, from development to industrialization with a set of scalable solutions for lentivirus production.
-
Digital Tech Transfer For Biopharma Manufacturing
3/11/2022
We understand the complexity of knowledge transfer within the modern manufacturing network, including the collaboration with multiple CMOs. BIOVIA Discoverant is a validation-ready solution for digital tech transfer in manufacturing.